Latest Rights Issue News

Prospech Limited has announced a 2-for-7 renounceable rights issue to raise up to $1.6 million, featuring attaching options exercisable at 4 cents. Directors are backing the raise, which will fund rare earth metallurgical work and exploration in Finland and Slovakia.

Halo Technologies Holdings Ltd reported a $6.06 million half-year loss, narrowing from last year’s $8.04 million, while preparing an $11 million rights issue to bolster its finances amid auditor concerns over asset valuations.

BauMart Holdings Limited has dramatically reduced its net loss to just $123,086 in FY25, down from $4.68 million the previous year, amid a strategic pivot and successful capital raise.

BauMart Holdings Limited has dramatically reduced its net loss to $123,086 for the year ended June 2025, down from $4.68 million the previous year, as it advances strategic initiatives and strengthens its financial position through a rights issue.

Eden Innovations Ltd reported a 21% revenue increase driven by global sales growth, yet its net loss widened significantly due to prior year asset revaluations and ongoing operational costs. The company is undertaking major financial restructuring including a share consolidation and rights issue to stabilize its balance sheet.

DTI Group Ltd reported an 11% revenue increase and secured a $4 million Adelaide Metro contract, alongside a $2.69 million capital raise to fuel growth. The company also deepened global partnerships and enhanced its technology platform during FY25.

Nanollose Limited reported a $1.43 million loss for FY2025 while progressing pilot production of innovative biomaterials and strengthening its balance sheet with a $2.1 million capital raise. The company appointed a new CEO to drive commercialisation efforts in FY2026.

Macarthur Minerals Limited reported a successful capital raise and key strategic partnerships at its 2025 AGM, positioning itself for future growth in iron ore production.

Skin Elements Limited reported a 13% revenue increase and a 20% reduction in net loss for FY2025, as it progresses commercial roll-out of its natural biotech products including ECO-Nurture and SuprCuvr.

Cann Group Limited reported a significant 56% reduction in net loss for FY25, driven by cost cuts and strong growth in dried flower sales, even as revenue declined due to shifting product preferences. The company faces going concern challenges but is actively pursuing debt refinancing and operational improvements.

The Hydration Pharmaceuticals Company Limited reported a 55% reduction in half-year losses to $1.44 million, driven by strategic cost reductions and a sharpened focus on US e-commerce operations. Despite a 15% revenue decline, the company is banking on new product launches and retail expansion to fuel growth.

FlexiRoam Limited reported an 8.6% revenue decline for FY25 but achieved a remarkable turnaround in the second half, posting positive EBITDA and net profit after a CEO-led operational reset.